RT Journal Article
SR Electronic
T1 Gamified closed-loop non-pharmacological intervention enhances tic suppression in children
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.04.17.24303913
DO 10.1101/2024.04.17.24303913
A1 Rotstein, Michael S.
A1 Zimmerman-Brenner, Sharon
A1 Davidovitch, Shiri
A1 BenHaim, Yael
A1 Koryto, Yuval
A1 Sion, Romi
A1 Rubinstein, Einat
A1 Djerassi, Meshi
A1 Lubiniaker, Nitzan
A1 Steinberg, Tamar
A1 Leitner, Yael
A1 Raz, Gal
YR 2024
UL http://medrxiv.org/content/early/2024/05/01/2024.04.17.24303913.abstract
AB Background The gamification of behavioral intervention for tic disorders (TDs) may not only enhance compliance with treatment protocols but also offer a key clinical advantage. By providing immediate positive feedback when tics are suppressed, games can counteract negative reinforcement processes that reinforce tics, which assumingly alleviates unpleasant premonitory urges. We developed a gamified protocol (XTics), which leverages this potential by combining gamified tic triggers with immediate reinforcement of tic suppression. We evaluate the clinical value of immediate reward contingency in enhancing tic suppression performance.Methods XTics comprises two conditions: tic-contingent and non-contingent. In the ticcontingent version, game progression was determined by real-time input from an experimenter who monitored the participant’s tics, rewarding tic suppression with favorable outcomes. Conversely, in the non-contingent version, game events occurred randomly. Using a crossover design, we trained 35 participants (aged 7-15) in both versions, with each participant undergoing a preliminary behavioral training and three hourly sessions for each condition. We both evaluated the overall protocol’s four-week impact on tic severity measures and compared contingent and non-contingent conditions.Results We achieved complete adherence to the protocol, while the participants increased their tic-free intervals by an average of 558% from the first to the last training day. YGTSS, a clinical measure of tic severity, showed an average clinically meaningful reduction of 25.69±23.39%, which was larger than that observed in control interventions and comparable to the effects of longer non-pharmacological treatments. Parent-reported tic severity decreased by 42.99±31.69% from baseline to three months post-treatment. When contrasting the ticcontingent with the tic-non-contingent training versions, we observed a larger improvement in tic-free interval duration in the former case (t(67)=3.15, p=.0025). Additionally, Rush, another measure of tic severity, demonstrated a greater reduction following training with the contingent compared to the non-contingent version (t(47)=3.47, p=.002).Conclusion The combination of gamified tic triggering with immediate and contingent rewards demonstrates a promising approach for enhancing treatment efficacy in TDs, offering an engaging boost to traditional therapeutic methods.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT06348511Funding StatementThis work was funded by the Young Investigator Award from the Tourette Association of America and the Brainboost Innovation Center at the Sagol School of Neuroscience, Tel Aviv University.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the ethical committee of the Tel-Aviv Sourasky Medical Center.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors under the hospital's constraints